TY - JOUR
T1 - Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets
AU - Suthram, Silpa
AU - Dudley, Joel T.
AU - Chiang, Annie P.
AU - Chen, Rong
AU - Hastie, Trevor J.
AU - Butte, Atul J.
PY - 2010/2
Y1 - 2010/2
N2 - Current work in elucidating relationships between diseases has largely been based on pre-existing knowledge of disease genes. Consequently, these studies are limited in their discovery of new and unknown disease relationships. We present the first quantitative framework to compare and contrast diseases by an integrated analysis of disease-related mRNA expression data and the human protein interaction network. We identified 4,620 functional modules in the human protein network and provided a quantitative metric to record their responses in 54 diseases leading to 138 significant similarities between diseases. Fourteen of the significant disease correlations also shared common drugs, supporting the hypothesis that similar diseases can be treated by the same drugs, allowing us to make predictions for new uses of existing drugs. Finally, we also identified 59 modules that were dysregulated in at least half of the diseases, representing a common disease-state "signature". These modules were significantly enriched for genes that are known to be drug targets. Interestingly, drugs known to target these genes/proteins are already known to treat significantly more diseases than drugs targeting other genes/proteins, highlighting the importance of these core modules as prime therapeutic opportunities.
AB - Current work in elucidating relationships between diseases has largely been based on pre-existing knowledge of disease genes. Consequently, these studies are limited in their discovery of new and unknown disease relationships. We present the first quantitative framework to compare and contrast diseases by an integrated analysis of disease-related mRNA expression data and the human protein interaction network. We identified 4,620 functional modules in the human protein network and provided a quantitative metric to record their responses in 54 diseases leading to 138 significant similarities between diseases. Fourteen of the significant disease correlations also shared common drugs, supporting the hypothesis that similar diseases can be treated by the same drugs, allowing us to make predictions for new uses of existing drugs. Finally, we also identified 59 modules that were dysregulated in at least half of the diseases, representing a common disease-state "signature". These modules were significantly enriched for genes that are known to be drug targets. Interestingly, drugs known to target these genes/proteins are already known to treat significantly more diseases than drugs targeting other genes/proteins, highlighting the importance of these core modules as prime therapeutic opportunities.
UR - http://www.scopus.com/inward/record.url?scp=77649222972&partnerID=8YFLogxK
U2 - 10.1371/journal.pcbi.1000662
DO - 10.1371/journal.pcbi.1000662
M3 - Article
C2 - 20140234
AN - SCOPUS:77649222972
SN - 1553-734X
VL - 6
JO - PLoS Computational Biology
JF - PLoS Computational Biology
IS - 2
M1 - e1000662
ER -